Equities

CERo Therapeutics Holdings Inc

CERO:NMQ

CERo Therapeutics Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.119
  • Today's Change0.032 / 36.78%
  • Shares traded156.74m
  • 1 Year change-98.91%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at CERo Therapeutics Holdings Inc fell by 42.04m. In addition, the company used more cash to support its operations than it earned, posting a cash flow loss of 1.52m. In addition the company used 7.94m on investing activities and also paid 32.58m in financing cash flows.
Cash flow per share-0.3843
Price/Cash flow per share--
Book value per share-0.9226
Tangible book value per share-0.9226
More ▼

Balance sheet in USDView more

CERo Therapeutics Holdings Inc uses little or no debt in its capital structure.
Current ratio1.65
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.